Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the five ratings firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have issued a buy recommendation on the company.
Several analysts have weighed in on the company. Morgan Stanley lowered their target price on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating on the stock in a report on Friday, March 6th. KeyCorp lowered their target price on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, March 5th. Wall Street Zen lowered Stevanato Group from a “buy” rating to a “hold” rating in a report on Saturday, February 14th. Jefferies Financial Group set a $17.50 target price on Stevanato Group in a report on Tuesday, February 10th. Finally, Weiss Ratings lowered Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 11th.
Read Our Latest Analysis on STVN
Institutional Trading of Stevanato Group
Stevanato Group Trading Up 0.2%
NYSE:STVN opened at €19.03 on Monday. The stock has a fifty day moving average price of €15.11 and a two-hundred day moving average price of €18.80. The stock has a market capitalization of $5.76 billion, a price-to-earnings ratio of 32.82, a PEG ratio of 1.63 and a beta of 0.75. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.26 and a current ratio of 1.76. Stevanato Group has a 1 year low of €12.89 and a 1 year high of €28.00.
Stevanato Group (NYSE:STVN – Get Free Report) last released its quarterly earnings data on Saturday, February 14th. The company reported €0.18 earnings per share (EPS) for the quarter. The firm had revenue of €346.50 million during the quarter. Stevanato Group had a return on equity of 10.44% and a net margin of 11.83%. As a group, sell-side analysts anticipate that Stevanato Group will post 0.7 earnings per share for the current fiscal year.
About Stevanato Group
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Further Reading
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
